Filings a company makes when something has gone wrong, or is about to: a missed reporting deadline (NT 10-K/Q), a delisting from its exchange (Form 25), a deregistration that ends SEC reporting altogether (Form 15), or an insider's notice of intent to sell restricted stock (Form 144). Any one can be routine — Form 144s are filed constantly, and a late filing is sometimes just a late filing — so what is worth reading here is the pattern and the timing.
The Quarterly report on Form 10-Q for the period ended March 31, 2026 (“Quarterly Report”) of Akari Therapeutics, Plc (the “Company”) could not be filed on schedule due to management and counsel de...
Akari Therapeutics, plc (the “Company”) will be unable to file its Annual Report on Form 10-K for the year ended December 31, 2024 (the “Form 10-K”) within the prescribed time period without unreas...
3 more red-flag filings behind a free account
See every red-flag filing Akari Therapeutics PLC has made, with the filing behind each one.
Sign up freeLoading...
